{"nct_id":"NCT07062965","title":"A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2025-08-05","start_date_type":"ACTUAL","primary_completion_date":"2027-07-22","primary_completion_date_type":"ESTIMATED","completion_date":"2030-11-04","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["PFE"]}